Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 4Phase 4 2Phase 1/2 2

Status

Unknown 6Completed 4Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 1Lung Neoplasms 1Brain Neoplasms 1

Interventions

Cyclophosphamide 299Cisplatin 298Paclitaxel 257Radiotherapy 255Fluorouracil 234Carboplatin 234Docetaxel 230Doxorubicin 216Dexamethasone 166Gemcitabine 156Vincristine 147Etoposide 136Leucovorin 133Capecitabine 129Bevacizumab 129Prednisone 125Rituximab 118Methotrexate 118Cytarabine 110Filgrastim 99Trastuzumab 97Oxaliplatin 96pembrolizumab 83Pemetrexed 73Epirubicin 70Tamoxifen 69Drug Therapy 69Irinotecan 65Granulocyte Colony-Stimulating Factor 60Daunorubicin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Completed × icotinib × Clear all
NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Shanghai University of Traditional Chinese Medicine

Phase 3 Completed
23 enrolled
Thoracic

Lung Neoplasms, Neoplasms

NCT01724801 2017-03-01

BRAIN

Guangdong Association of Clinical Trials

Phase 3 Completed
176 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02486354 2015-07-01

Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy

Betta Pharmaceuticals Co., Ltd.

Phase 3 Completed
128 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01040780 2014-02-14

ICOGEN

Betta Pharmaceuticals Co., Ltd.

Phase 3 Completed
399 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡